Enhanced neointimal hyperplasia and carotid artery remodelling in sequestosome 1 deficient mice

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 6 B, 2010, Pages 1546-1554

  Sugimoto, Rika ^a   Warabi, Eiji ^a   Katayanagi, Satoru ^a   Sakai, Satoshi ^a   Uwayama, Junya ^a   Yanagawa, Toru ^a   Watanabe, Ayaka ^a   Harada, Harumi ^a   Kitamura, Kiyoshi ^a   Noguchi, Noriko ^b   Yoshida, Hiroshi ^a   Siow, Richard C M ^c   Mann, Giovanni E ^c   Ishii, Tetsuro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b DOSHISHA UNIVERSITY   (Japan)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Carotid artery; ERK1 2; Neointimal hyperplasia; P38MAPK; Sequestosome 1; Smooth muscle proliferation; Vascular injury; Vascular remodelling

Indexed keywords

DNA; HEAT SHOCK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE INHIBITOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SQSTM1 PROTEIN, MOUSE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; COMMON CAROTID ARTERY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; FLOW CYTOMETRY; HYPERPLASIA; INTIMA; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; SMOOTH MUSCLE FIBER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CAROTID ARTERY, COMMON; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CORONARY CIRCULATION; DNA; ENZYME ACTIVATION; FLOW CYTOMETRY; HEAT-SHOCK PROTEINS; HYPERPLASIA; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; TUNICA INTIMA;

MUS;

EID: 77955132853     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00914.x     Document Type: Article

References (38)

1. Moscat J, Diaz-Meco MT, Wooten MW. Signal integration and diversification through the p62 scaffold protein. Trends Biochem Sci. 2007, 32:95-100.
2. Ishii T, Yanagawa T, Kawane T. Murine peritoneal macrophages induce a novel 60-kDa protein with structural similarity to a tyrosine kinase p56lck-associated protein in response to oxidative stress. Biochem Biophys Res Commun. 1996, 226:456-60.
3. Puls A, Schmidt S, Grawe F. Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein. Proc Natl Acad Sci USA. 1997, 94:6191-6.
4. Joung I, Strominger JL, Shin J. Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain. Proc Natl Acad Sci USA. 1996, 93:5991-5.
5. Sanz L, Sanchez P, Lallena MJ. The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. EMBO J. 1999, 18:3044-53.
6. Sanz L, Diaz-Meco MT, Nakano H. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J. 2000, 19:1576-86.
7. Vadlamudi RK, Joung I, Strominger JL. p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem. 1996, 271:20235-7.
8. Shin J. P62 and the sequestosome, a novel mechanism for protein metabolism. Arch Pharm Res. 1998, 21:629-33.
9. Rodriguez A, Duran A, Selloum M. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab. 2006, 3:211-22.
10. Ishii T, Itoh K, Takahashi S. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem. 2000, 275:16023-9.
11. Ishii T, Itoh K, Ruiz E. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ Res. 2004, 94:609-16.
12. Leonarduzzi G, Chiarpotto E, Biasi F. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res. 2005, 49:1044-9.
13. Warabi E, Wada Y, Kajiwara H. Effect on endothelial cell gene expression of shear stress, oxygen concentration, and low-density lipoprotein as studies by a novel flow cell culture system. Free Radic Biol Med. 2004, 37:682-94.
14. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol. 1997, 17:2238-44.
15. Rectenwald JE, Moldawer LL, Huber TS. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation. 2000, 102:1697-702.
16. Ohashi N, Matsumori A, Furukawa Y. Role of p38 mitogen-activated protein kinase in neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol. 2000, 20:2521-6.
17. Izumi Y, Kim S, Namba M. Gene transfer of dominant-negative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in balloon-injured rat artery. Circ Res. 2001, 88:1120-6.
18. Zhan Y, Kim S, Izumi Y. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arterioscler Thromb Vasc Biol. 2003, 23:795-801.
19. Ju H, Nerurkar S, Sauermelch CF. Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury. J Pharmacol Exp Ther. 2002, 301:15-20.
20. Jacob T, Ascher E, Alapat D. Activation of p38MAPK signaling cascade in a VSMC injury model: role of p38MAPK inhibitors in limiting VSMC proliferation. Eur J Vasc Endovasc Surg. 2005, 29:470-8.
21. Harmon KJ, Couper LL, Lindner V. Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol. 2000, 156:1741-8.
22. Komatsu M, Waguri S, Koike M. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007, 131:1149-63.
23. Murakoshi N, Miyauchi T, Kakinuma Y. Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice. Circulation. 2002, 106:1991-8.
24. Pyles JM, March KL, Franklin M. Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ Res. 1997, 81:904-10.
25. Gennaro G, Menard C, Michaud SE. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor. Circulation. 2004, 110:3367-71.
26. Proctor BM, Jin X, Lupu TS. Requirement for p38 mitogen-activated protein kinase activity in neointima formation after vascular injury. Circulation. 2008, 118:658-66.
27. Jacob A, Smolenski A, Lohmann SM. MKP-1 expression and stabilization and cGK Ialpha prevent diabetes- associated abnormalities in VSMC migration. Am J Physiol Cell Physiol. 2004, 287:C1077-86.
28. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001, 410:37-40.
29. Liu Y, Poon RT, Shao W. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma. Cancer Lett. 2007, 248:32-40.
30. Fox CS, Massaro JM, Hoffmann U. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007, 116:39-48.
31. Rodford JL, Torrens C, Siow RC. Endothelial dysfunction and reduced antioxidant protection in an animal model of the developmental origins of cardiovascular disease. J Physiol. 2008, 586:4709-20.
32. Despres JP, Lemieux I, Bergeron J. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008, 28:1039-49.
33. Okada K, Yanagawa T, Warabi E. The α-glucosidase inhibitor acarbose prevents obesity and simple steatosis in sequestosome 1/A170/p62 deficient mice. Hepatol Res. 2009, 39:490-500.
34. Kawai K, Saito A, Sudo T. Specific regulation of cytokine-dependent p38 MAP kinase activation by p62/SQSTM1. J Biochem. 2008, 143:765-72.
35. Geetha T, Wooten MW. Association of the atypical protein kinase C-interacting protein p62/ZIP with nerve growth factor receptor TrkA regulates receptor trafficking and Erk5 signaling. J Biol Chem. 2003, 7:4730-9.
36. Pankiv S, Clausen TH, Lamark T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007, 282:24131-45.
37. Sundaresan M, Yu ZX, Ferrans VJ. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science. 1995, 270:296-9.
38. Choi MH, Lee IK, Kim GW. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature. 2005, 435:347-53.